BIS

ProShares UltraShort NASDAQ Biotechnology
*Unless otherwise stated, data provided by FactSet.

BIS Fund Description

BIS provides -2x exposure to a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ.

BIS Factset Analytics Insight

BIS is one available fund that provides exposure to the biotech space — aiming for daily geared inverse (-2x) exposure to the NASDAQ Biotechnology Index (comprised of companies that are classified as either biotechnology or pharmaceutical). The fund expects to typically hold derivatives and money market instruments. Note: BIS is a tactical tool, it is not a buy-and-hold investment and should not be expected to provide index leverage returns greater than a one-day period.

PERFORMANCE [as of 12/01/21] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
BIS 7.24% 20.93% -15.08% -23.09% -35.19% -31.22% -38.81%
BIS (NAV) 15.84% 28.87% -11.48% -19.19% -34.20% -31.09% -38.51%
NASDAQ Biotechnology Index -- -- -- -- -- -- --
N/A -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

BIS Summary Data

ProShares
04/07/10
Open-Ended Fund
0.95%
$6.91M
0.25%
N/A

BIS Portfolio Data

0.47%
N/A

BIS Index Data

Market Cap
NASDAQ - Listed
N/A

BIS Fund Structure

Yes
No
-- / --
N/A
N/A
High
-2
Daily

BIS Tax Exposures

20.00% / 39.60%
--
No

BIS Factset Analytics Block Liquidity

As of 12/02/21
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of BIS. BIS is rated a N/A out of 5.

BIS Tradability

9,544
$180.99K
4,714
$86.38K
0.25%
$0.05
0.00%
0.58% / -0.65%
None
97.00%
50,000
0.09
0.03%
--
159
$20.86
N/A